Poppins (Series A)
Funding Details
- Awarder
- Inbox
- Date Award
- April 24, 2025
- Vertical
- Medtech
- Funding URL
- View Funding Page
- Funding Amount:
- $5,000,000
Company Info
- Founding Year
- 2018
- Traction
- Poppins has undergone numerous preliminary studies, involving over 6,000 families across France, and has demonstrated clinical benefit through comparative clinical trials.
- Organizations Involved
- MAE, Allianz France, Abeille Assurance, Groupe Pasteur Mutualité, PRO BTP, IRCEM, Kerialis, Audiens, Radio France
- Founders
- François Vonthron, Antoine Yuen
- Company Description
- Poppins is a startup specializing in medical devices for managing neurodevelopmental disorders, particularly dyslexia, which accounts for 80% of learning disorders. The medical device offers a structured training protocol through a video game comprising 31 written language and rhythm exercises, accessible on a tablet or smartphone.
- Market
- Dyslexia therapy for children
- Location
- France
- Coinvestors
- Racine2, Bpifrance’s Patient Autonome fund, Eurazeo, Kurma Partners, BNP Paribas Développement, Verve Ventures